Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection

Summary

To evaluate the efficacy and safety of direct acting anti-viral agents (DAA) therapy in chronically infected Hepatitis C Virus (HCV) patients using an individualized response guided therapy (RGT) model.

Timeline

Start

2018-02-25

Primary completion

2020-12-31

Completion

2020-12-31

Publications

• Etzion O, Dahari H, Yardeni D, Issachar A, Nevo-Shor A, Cohen-Naftaly M, Ashur Y, Uprichard SL, Arbib OS, Munteanu D, Braun M, Cotler SJ, Abufreha N, Keren-Naus A, Shemer-Avni Y, Mor O, Murad J, Novack V, Shlomai A. Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study. Sci Rep. 2020 Oct 20;10(1):17820. doi: 10.1038/s41598-020-74568-x.

Drugs

Indications